# Histopathological Confirmed Polycythemia Vera with Transformation to Myelofibrosis Depicted on [18F]FDG PET/CT

**Authors:** Moritz B. Bastian, Arne Blickle, Caroline Burgard, Octavian Fleser, Konstantinos Christofyllakis, Samer Ezziddin, Florian Rosar

PMC · DOI: 10.3390/diagnostics14100982 · Diagnostics · 2024-05-08

## TL;DR

A case study shows how PET/CT imaging can detect the progression of polycythemia vera to myelofibrosis.

## Contribution

This case highlights the utility of [18F]FDG PET/CT in identifying myelofibrosis transformation in polycythemia vera.

## Key findings

- PET/CT imaging showed intense bone marrow and spleen metabolic activity in a PV patient.
- Bone marrow biopsy confirmed transformation to myelofibrosis despite initial PV diagnosis.
- The case illustrates the potential of PET/CT for monitoring PV progression.

## Abstract

We present a case of a 59-year-old male diagnosed with polycythemia vera (PV) for many years, who presented with a relatively abrupt onset of heavy constitutional symptoms, including fatigue, night sweats, and a 10% weight loss over 6 weeks. Despite the known initial diagnosis of PV, the presence of profound B-symptoms prompted further investigation. A positron emission tomography/computed tomography (PET/CT) scan with 18F-Fluorodeoxyglucose ([18F]FDG) was performed to exclude malignant diseases. The [18F]FDG PET/CT revealed intense metabolic activity in the bone marrow of the proximal extremities and trunk skeleton, as well as a massively enlarged spleen with increased metabolic activity. Histopathologically, a transformation to myelofibrosis was revealed on a bone marrow biopsy. The case intends to serve as an exemplification for [18F]FDG PET/CT in PV with transformation to myelofibrosis (post-PV myelofibrosis).

## Linked entities

- **Chemicals:** 18F-Fluorodeoxyglucose (PubChem CID 68614), [18F]FDG (PubChem CID 68614)
- **Diseases:** polycythemia vera (MONDO:0009891), myelofibrosis (MONDO:0044903)

## Full-text entities

- **Diseases:** fatigue (MESH:D005221), weight loss (MESH:D015431), B-symptoms (MESH:D006509), sweats (MESH:D013543), constitutional symptoms (MESH:D005878), PV (MESH:D011087), malignant diseases (MESH:D009369), Myelofibrosis (MESH:D055728)
- **Chemicals:** 18F-Fluorodeoxyglucose (MESH:D019788)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11120594/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC11120594/full.md

---
Source: https://tomesphere.com/paper/PMC11120594